<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian Journal of War and Public Health</title>
<title_fa>طب جانباز</title_fa>
<short_title>Iran J War Public Health</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ijwph.ir</web_url>
<journal_hbi_system_id>153</journal_hbi_system_id>
<journal_hbi_system_user>ijwph</journal_hbi_system_user>
<journal_id_issn>2008-2622</journal_id_issn>
<journal_id_issn_online>2008-2630</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.58209/ijwph</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1401</year>
	<month>10</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2023</year>
	<month>1</month>
	<day>1</day>
</pubdate>
<volume>15</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Comparison of Visfatin and Leptin Levels in Type 2 Diabetic Patients with and without Atherosclerosis</title>
	<subject_fa>آسیب‌های جنگ/حادثه و عوارض آن</subject_fa>
	<subject>War/Accident Related Injuries and its Complications</subject>
	<content_type_fa>توصیفی و نظرسنجی</content_type_fa>
	<content_type>Descriptive &amp; Survey</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;span style=&quot;font-size:10pt&quot;&gt;&lt;span style=&quot;text-autospace:none&quot;&gt;&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;span cambria=&quot;&quot; style=&quot;font-family:&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;Aims: &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span cambria=&quot;&quot; style=&quot;font-family:&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;Medical evidence shows that Visfatin and Leptin are related to multiple metabolic Problems, including obesity, type 2 diabetes, and cardiovascular disease. The present study aimed to assess Visfatin and Leptin levels in type 2 diabetic patients with and without atherosclerosis.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:10pt&quot;&gt;&lt;span style=&quot;text-autospace:none&quot;&gt;&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;span cambria=&quot;&quot; style=&quot;font-family:&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;Instruments &amp; Methods: &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span cambria=&quot;&quot; style=&quot;font-family:&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;This descriptive study was conducted on 30 diabetic patients, 30 patients with diabetes mellitus and atherosclerosis, and 30 seemingly healthy persons (as a control group) in Babylon Province, Iraq, and their serum Visfatin and Leptin levels were assessed by ELISA procedure. The statistical analysis was done with SPSS 21 software.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:10pt&quot;&gt;&lt;span style=&quot;text-autospace:none&quot;&gt;&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;span cambria=&quot;&quot; style=&quot;font-family:&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;Findings:&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span cambria=&quot;&quot; style=&quot;font-family:&quot;&gt;&lt;span style=&quot;color:black&quot;&gt; In diabetic patients and patients with diabetes and atherosclerosis, the level of Visfatin was significantly higher than in the control group (p=0.0001). There was a significant increase in Leptin level in diabetic patients compared to the control group (p=0.0001), while Leptin level showed a significant decrease in patients with diabetes and atherosclerosis than in the control group (p=0.0001). Also, the mean body mass index in diabetic patients and patients with diabetes and atherosclerosis was significantly higher than in the control group (p=0.0001).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:10pt&quot;&gt;&lt;span style=&quot;text-autospace:none&quot;&gt;&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; style=&quot;font-family:&quot; times=&quot;&quot;&gt;&lt;b&gt;&lt;span cambria=&quot;&quot; style=&quot;font-family:&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;Conclusion:&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span cambria=&quot;&quot; style=&quot;font-family:&quot;&gt;&lt;span style=&quot;color:black&quot;&gt; Visfatin serum levels are significantly higher in atherosclerosis patients compared to healthy people, while low Leptin and high Visfatin expression are seen in patients with diabetes.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&amp;nbsp;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Type 2 Diabetes Mellitus,Atherosclerosis,Leptin,Visfatin,Body Mass Index,Iraq,</keyword>
	<start_page>11</start_page>
	<end_page>15</end_page>
	<web_url>http://ijwph.ir/browse.php?a_code=A-10-2037-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>W.Z. </first_name>
	<middle_name></middle_name>
	<last_name>Mohi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>15300319475328460027653</code>
	<orcid>15300319475328460027653</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Biochemistry Department, College of Medicine, University of Babylon, Hilla, Iraq</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>K.A. </first_name>
	<middle_name></middle_name>
	<last_name>Shemran</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>15300319475328460027654</code>
	<orcid>15300319475328460027654</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Biochemistry Department, College of Medicine, University of Babylon, Hilla, Iraq</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Y.</first_name>
	<middle_name></middle_name>
	<last_name>Alsaffar</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>15300319475328460027655</code>
	<orcid>15300319475328460027655</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Biochemistry Department, College of Medicine, University of Babylon, Hilla, Iraq</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
